Fetal and neonatal alloimmune thrombocytopenia is considered to be one of the rarest known diseases, occurring in 1 in 800 live births.
The disease occurs in the fetus or newborn baby when the mother’s antibodies attack and destroy the baby’s platelets. Bleeding episodes affecting the brain are a significant risk, occurring in 20 percent of reported deaths.